Screener
TG Therapeutics TGTX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $7.78M-72.4% | $19.78M+291% | $23.04M-1.3% | $390.9M+9,975% | $28.19M+310% | ||
| $53K+308% | $32K+300% | $21K+133% | $17K+54.5% | $13K-31.6% | ||
| $27.88M+70.4% | $19.95M+33.2% | $15.65M+31.0% | $17.69M+50.2% | $16.36M+72.6% | ||
| $39.26M— | -$17.89M+37.7% | —— | -$23.15M-89.7% | —— | ||
| $293K+598% | $51K+104% | $67K+219% | $80K+233% | $42K— | ||
| —— | -$9.86M+23.7% | —— | $46.36M+597% | -$3.99M— | ||
| —— | $99.99M+1,533% | $0-100% | $78.24M+3,541% | $6.88M— | ||
| —— | $747.66M— | $0— | $0-100% | $0— | ||
| $85K+101% | $390.83M+6,505% | $0— | -$78.24M-158% | -$6.44M-4,873% | ||
| $40.38M+1,446% | $363.07M+860% | $0— | -$55.03M-149% | -$3M— | ||
| $38.97M— | -$17.95M+37.6% | —— | -$23.23M-90.0% | —— |
FAQ
- How much cash does TG Therapeutics generate?
- TG Therapeutics (TGTX) generated -$30.5M in operating cash flow over the trailing twelve months.
- What is TG Therapeutics's free cash flow?
- After $491.0K of capital expenditures, TG Therapeutics's free cash flow was -$30.9M over the trailing twelve months, up 47.8% year over year.
- Where does TG Therapeutics's cash flow data come from?
- Every line is extracted from TG Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
